Your browser doesn't support javascript.
loading
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma.
Cardona, A F; Rojas, L; Wills, B; Ruiz-Patiño, A; Abril, L; Hakim, F; Jiménez, E; Useche, N; Bermúdez, S; Mejía, J A; Ramón, J F; Carranza, H; Vargas, C; Otero, J; Archila, P; Rodríguez, J; Rodríguez, J; Behaine, J; González, D; Jacobo, J; Cifuentes, H; Feo, O; Penagos, P; Pineda, D; Ricaurte, L; Pino, L E; Vargas, C; Marquez, J C; Mantilla, M I; Ortiz, L D; Balaña, C; Rosell, R; Zatarain-Barrón, Z L; Arrieta, O.
Afiliação
  • Cardona AF; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Calle 116 No. 9-72, c. 318, Bogotá, Colombia. a_cardonaz@yahoo.com.
  • Rojas L; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia. a_cardonaz@yahoo.com.
  • Wills B; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia. a_cardonaz@yahoo.com.
  • Ruiz-Patiño A; Clinical Oncology Department, Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia.
  • Abril L; Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Hakim F; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Jiménez E; Internal Medicine Department, Johns Hopkins University, Baltimore, MD, USA.
  • Useche N; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Bermúdez S; Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Mejía JA; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Ramón JF; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Carranza H; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • Vargas C; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Otero J; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • Archila P; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Rodríguez J; Division of Neuro-radiology, Radiology Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • Rodríguez J; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Behaine J; Division of Neuro-radiology, Radiology Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • González D; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Jacobo J; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • Cifuentes H; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Feo O; Neurosurgery Department, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
  • Penagos P; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Calle 116 No. 9-72, c. 318, Bogotá, Colombia.
  • Pineda D; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Ricaurte L; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Calle 116 No. 9-72, c. 318, Bogotá, Colombia.
  • Pino LE; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Vargas C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Marquez JC; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Mantilla MI; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Ortiz LD; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia.
  • Balaña C; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Rosell R; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Zatarain-Barrón ZL; Institute of Neuroscience, Universidad El Bosque, Bogotá, Colombia.
  • Arrieta O; Neurosurgery Department, Clínica del Country, Bogotá, Colombia.
Clin Transl Oncol ; 21(10): 1364-1373, 2019 Oct.
Article em En | MEDLINE | ID: mdl-30798512

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carmustina / Glioblastoma / Inibidores da Angiogênese / Bevacizumab / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies País/Região como assunto: America do sul / Colombia Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carmustina / Glioblastoma / Inibidores da Angiogênese / Bevacizumab / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies País/Região como assunto: America do sul / Colombia Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Itália